Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00035024.xml
Thromb Haemost 1976; 35(03): 643-650
DOI: 10.1055/s-0038-1647963
DOI: 10.1055/s-0038-1647963
Original Article
Plasmin inactivation in Plasma
Further Information
Publication History
Received
06 October 1975
Accepted
12 December 1975
Publication Date:
24 July 2018 (online)
![](https://www.thieme-connect.de/media/10.1055-s-00035024/197601/lookinside/thumbnails/10-1055-s-0038-1647963-1.jpg)
Summary
Inhibition and inactivation of plasmin is ascribed to α2-macroglobulin, α1-antitrypsin and c1-esterase inhibitor. In an “overall” inactivation test of plasmin in plasma, which comes perhaps closest to rapid inactivation of plasmin in the circulating blood, we only found a correlation between the immunological concentration of α2-macroglobulin and the plasmin-inac-tivating capacity of the plasma, but no correlation with the immunological concentration of the other inhibitors mentioned. Therefore, α2-macroglobulin seems to be the most important plasmin inhibitor in relation to thrombosis.
-
References
- 1 Aberg M, Nilsson I. M, Hedner U. 1973; Antithrombin III after operation. Lancet II: 1337.
- 2 Amris C. J, Larsen V, Mogensen B, Storm O. 1963; Infusion of porcine plasmin in man. Scandinavian Journal of Clinical and Laboratory, Investigation 15: 179.
- 3 Barrett A. J, Starkey P. M. 1973; The interaction of α2-macroglobulin with proteinases. Biochemical Journal 133: 709.
- 4 Biggs R, Denson K. W. E, Akman N, Borrett R, Hadden M. 1970; Antithrombin III, antifactor Xa and heparin. British Journal of Haematology 19: 287.
- 5 Blatrix C, Amouch P, Dronet J, Steinbuch M. 1973 Study on the plasmatic elimination of the α2-M proteinase complexes. Pathologie – Biologie. 20. Suppl. II.
- 6 Boyde T. R. C, Pryme E. F. 1968; α2-microglobulin binding of trypsin, chymotrypsin/papain, and cationic asparate aminotransferase. Clinica Chimica Acta 21: 9.
- 7 Collen D, de Cock F, Verstraete M. 1975; Immunochemical distinction between antiplasmin and α1antitrypsin. Thrombosis Research 7: 245.
- 8 Colman R. W. 1974; Formation of human kinin. New England Journal of Medicine 291: 509.
- 9 Donati M. B, Vandenberghe K, Molla A, de Roo M, Verstraete M. 1973; Postoperative antithrombin III. Lancet I: 726.
- 10 Ganrot P. O. 1966; Determination of α2-macroglobulin as trypsinprotein esterase. Clinica Chimica Acta 14: 493.
- 11 Ganrot P. O, Schersten B. 1967; Serum α2-macroglobulin concentration and its variation with age and sex. Clinica Chimica Acta 15: 113.
- 12 Ganrot P. O. 1967; Inhibition of plasmin activity by α2-macroglobulin. Clinica Chimica Acta 16: 328.
- 13 Ganrot P. O, Nilehn J. E. 1967; Competition between plasmin and thrombin for α2-macroglobulin. Clinica Chimica Acta 17: 511.
- 14 Ganrot P. O. 1967; Interaction of plasmin and trypsin with α2-macroglobulin. Acta Chemia Scan-dinavica 21: 602.
- 15 Harpel P. C. 1970; Human α2-macroglobulin. Journal of Experimental Medicine 132: 329.
- 16 Hedner U, Nilsson I. M. 1973; Antithrombin III in a clinical material. Thrombosis Research 3: 631.
- 17 Hedner U. 1974 Fibrinolytic inhibitors. Supplementum LIX ad Thrombosis et Diathesis Haemorrhagica. 281.
- 18 Laurell C. B. 1966; Quantitative estimation of proteins by electrophoresis in agarase gel containing antibodies. Analytical Biochemistry 15: 45.
- 19 Schreiber A. D, Kaplan A. P, Austen K. F. 1973; Plasmin inhibitors of the components of the fibrinolytic pathway in man. Journal of Clinical Investigation 52: 1394.
- 20 Stathakis N, Papyannis A. G, Gardikas C. D. 1973; Postoperative antithrombin III concentration. Lancet I: 430.
- 21 Strengers Th, Asberg E. G. M. 1963; Een Screeningtest, gevolgd door een snelle kwantitatieve microbepaling van fibrinogeen in plasma. Nederlands Tijdschrift voor Geneeskunde 107: 2044.
- 22 Yin E. T, Wessler S. 1970; Heparin-accelerated inhibition of activated factor X by its natural inhibitor. Biochemical Biophysical Acta 201: 387.
- 23 Yin E. T, Wessler S, Stoll P. 1971; Biological properties of the naturally occurring plasma inhibitor to activated factor X. Journal of Biological Chemistry 246: 3703.